Mounjaro & Ulcerative Colitis UK | Cured Pharmacy

Clinically Proven UK Registered Pharmacy

Cheapest Mounjaro and Ulcerative Colitis UK Price

Get Mounjaro from £124.99 at the cheapest UK price, plus £20 off your first order with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

WEIGHTLOSSNEW £20 off for new customers

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check if you're eligible

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£99 £79.00

£19.75 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £99
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy Oral Pill
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy Oral Pill
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy Oral Pill
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy Oral Pill
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

The Science Behind Mounjaro And Ulcerative Colitis

Published on: June 03, 2026

Understanding the relationship between Mounjaro and ulcerative colitis UK is essential for patients considering weight loss treatment alongside inflammatory bowel disease. Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist licensed for weight management in the UK, but its use in patients with ulcerative colitis requires careful clinical assessment by a UK prescriber who understands both conditions.

How Mounjaro Works in the Body

Mounjaro contains tirzepatide, the first dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA in the UK [1]. Unlike single-pathway medications, tirzepatide activates two complementary hormone systems that regulate appetite, glucose metabolism, and gastric emptying.

In the SURMOUNT-1 trial, participants achieved an average body weight reduction of 22.5% over 72 weeks on the 15mg maintenance dose — significantly higher than other weight loss medications currently available [1]. The medication works by slowing gastric emptying, reducing appetite signals to the brain, and improving insulin sensitivity in peripheral tissues.

Tirzepatide's mechanism involves binding to GIP and GLP-1 receptors throughout the gastrointestinal tract, pancreas, and central nervous system. This widespread receptor distribution means the medication affects multiple organ systems, which is particularly relevant for patients with pre-existing gastrointestinal conditions like ulcerative colitis.

Understanding Ulcerative Colitis and Gastrointestinal Medications

Ulcerative colitis is a chronic inflammatory bowel disease characterising inflammation and ulceration of the colon and rectum. Patients typically experience symptoms including abdominal pain, bloody diarrhoea, urgency, and weight fluctuations during disease flares [2].

The gastrointestinal side effects of Mounjaro — including nausea, diarrhoea, vomiting, and abdominal discomfort — occur in a significant proportion of patients, particularly during dose escalation [3]. These effects result from the medication's action on GLP-1 receptors in the gut, which slow gastric emptying and affect intestinal motility.

For patients with ulcerative colitis, distinguishing between IBD symptoms and medication side effects becomes clinically important. A UK prescriber must assess whether the gastrointestinal effects of tirzepatide might complicate disease monitoring, exacerbate existing symptoms, or interfere with ulcerative colitis management.

Gastrointestinal Side Effects Profile

In clinical trials, nausea occurred in approximately 20-30% of Mounjaro patients, diarrhoea in 15-20%, and vomiting in 8-10%, with most cases being mild to moderate and resolving over time [3]. These percentages represent the general population without pre-existing inflammatory bowel disease, so individual risk assessment is essential for ulcerative colitis patients.

Clinical Considerations for Mounjaro and Ulcerative Colitis UK Patients

No large-scale clinical trials have specifically examined tirzepatide use in patients with active ulcerative colitis, which means prescribers must make individualised risk-benefit assessments. The SURMOUNT and SURPASS trial programmes excluded patients with significant gastrointestinal disease, creating a knowledge gap for this patient population [1][4].

UK prescribers evaluating Mounjaro for patients with ulcerative colitis typically consider several factors: current disease activity, symptom stability, previous medication tolerance, nutritional status, and the ability to distinguish between IBD flares and medication side effects. Patients in remission with well-controlled ulcerative colitis may be considered differently than those with active disease.

The slowed gastric emptying caused by tirzepatide may affect the absorption of oral ulcerative colitis medications, including aminosalicylates and immunosuppressants. Your prescriber will review all current medications to assess potential interactions and timing considerations. Some patients may require more frequent monitoring during the initial treatment period.

When Mounjaro May Not Be Appropriate

Patients with severe or uncontrolled ulcerative colitis, those experiencing frequent disease flares, or individuals with complications such as toxic megacolon or severe malnutrition may not be suitable candidates for Mounjaro. A UK prescriber will assess your complete medical history, current disease status, and treatment goals before determining suitability.

Treatment Mechanism Administration Starting Price GI Side Effects
Mounjaro (tirzepatide) Dual GIP/GLP-1 agonist Weekly injection From £124.99 Moderate to high
Wegovy (semaglutide) GLP-1 agonist Weekly injection From £69.00 Moderate
Saxenda (liraglutide) GLP-1 agonist Daily injection From £68.00 Moderate
Orlistat Lipase inhibitor Oral capsule From £32.00 High (different type)
Mysimba Naltrexone/bupropion Oral tablet From £125.95 Low to moderate

Alternative Weight Loss Treatments for IBD Patients

Patients with ulcerative colitis who are not suitable candidates for Mounjaro have several alternative weight management options available through UK pharmacies. Each medication has a different mechanism of action and side effect profile that may be more compatible with inflammatory bowel disease.

Orlistat works by blocking fat absorption in the intestine rather than affecting appetite or gastric emptying. This mechanism may be preferable for some ulcerative colitis patients, though the medication can cause gastrointestinal side effects including oily stools and increased bowel frequency [5]. Your prescriber will consider whether these effects might complicate IBD symptom management.

Other GLP-1 receptor agonists like semaglutide (Wegovy) and liraglutide (Saxenda) have similar mechanisms to tirzepatide but may be prescribed at different doses or frequencies. Mysimba, which combines naltrexone and bupropion, works through central nervous system pathways rather than gastrointestinal mechanisms, potentially offering an alternative for patients with significant gut sensitivity.

The Clinical Assessment Process at Cured Pharmacy

All prescription weight loss medications available through Cured Pharmacy require completion of a clinical assessment by a UK-registered prescriber. For patients with ulcerative colitis or other inflammatory bowel diseases, this assessment includes detailed questions about disease history, current symptoms, medications, and previous treatment responses.

Our clinical team, overseen by Superintendent Pharmacist Tarun Kumar (GPhC 2233073), reviews each assessment individually to ensure patient safety and treatment appropriateness. Patients with complex medical histories may be asked to provide additional information or may be advised to consult their gastroenterologist before starting weight loss medication.

The assessment typically takes under three minutes to complete but provides essential information that allows prescribers to make informed decisions about medication suitability. Transparency is fundamental to our service — you'll see upfront pricing before completing your consultation, with Mounjaro available from £124.99 subject to prescriber approval.

What Information You'll Need to Provide

Be prepared to provide details about your ulcerative colitis diagnosis date, current disease activity, medications you're taking (including biologics and immunosuppressants), recent colonoscopy findings if available, and any complications you've experienced. Honest and complete information helps prescribers make the safest recommendations for your individual circumstances.

Monitoring and Safety Considerations for Mounjaro and Ulcerative Colitis UK Patients

Patients with ulcerative colitis who are prescribed Mounjaro require careful monitoring during the initial treatment period. You should maintain regular contact with both your gastroenterologist and the prescribing pharmacy to report any changes in bowel symptoms, disease activity, or medication tolerance.

Warning signs that require immediate medical attention include severe abdominal pain, bloody diarrhoea that worsens from baseline, signs of dehydration, fever, or any symptoms suggesting an ulcerative colitis flare. Because Mounjaro can cause gastrointestinal side effects, distinguishing between expected medication effects and disease progression is essential [3].

The dose escalation schedule for Mounjaro is designed to minimise side effects, starting at 2.5mg weekly and increasing gradually to maintenance doses of 5mg, 10mg, or 15mg based on response and tolerance [6]. Patients with ulcerative colitis may benefit from slower escalation or lower maintenance doses, which your prescriber will determine based on your individual response and symptom profile.

Scientific References

  1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
  2. Ungaro, R., Mehandru, S., Allen, P. B., Peyrin-Biroulet, L., & Colombel, J. F. (2017). Ulcerative colitis. The Lancet, 389(10080), 1756–1770. https://doi.org/10.1016/S0140-6736(16)32126-2 [accessed 13 August 2026]
  3. Dahl, D., Onishi, Y., Norwood, P., et al. (2022). Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial. JAMA, 327(6), 534–545. https://doi.org/10.1001/jama.2022.0078 [accessed 13 August 2026]
  4. Rosenstock, J., Wysham, C., Frías, J. P., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143–155. https://doi.org/10.1016/S0140-6736(21)01324-6 [accessed 13 August 2026]
  5. Sjöström, L., Rissanen, A., Andersen, T., et al. (1998). Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. The Lancet, 352(9123), 167–172. https://doi.org/10.1016/S0140-6736(97)11509-4 [accessed 13 August 2026]
  6. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/14298 [accessed 13 August 2026]
  7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
  8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
  9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Patients with ulcerative colitis or other inflammatory bowel diseases should discuss weight loss medication options with both their gastroenterologist and prescribing pharmacist. Always consult a qualified healthcare professional before starting any new medication, particularly if you have pre-existing gastrointestinal conditions.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Can I take Mounjaro if I have ulcerative colitis?
Mounjaro may be prescribed to patients with well-controlled ulcerative colitis after individual assessment by a UK prescriber. Patients with active or severe IBD may not be suitable candidates due to the medication's gastrointestinal side effects and the need to monitor disease activity clearly.
Will Mounjaro make my ulcerative colitis worse?
There is no evidence that tirzepatide directly worsens inflammatory bowel disease, but the gastrointestinal side effects (nausea, diarrhoea, abdominal discomfort) may complicate symptom monitoring or be difficult to distinguish from IBD flares. Your prescriber will assess your individual risk profile.
How do I know if symptoms are from Mounjaro or an ulcerative colitis flare?
Mounjaro side effects typically occur during dose escalation and improve over time, whereas ulcerative colitis flares often include bloody diarrhoea, urgency, and progressive worsening. Contact your healthcare provider if you experience new or worsening gastrointestinal symptoms to determine the cause.
Are there safer weight loss alternatives for patients with IBD?
Medications like Mysimba, which work through central nervous system pathways rather than gastrointestinal mechanisms, may be more suitable for some IBD patients. Your UK prescriber will recommend the most appropriate option based on your complete medical history and current disease status.
Does Mounjaro interact with ulcerative colitis medications?
Tirzepatide's effect on gastric emptying may affect the absorption timing of oral medications including mesalazine and immunosuppressants. Your prescriber will review all current medications and may recommend taking certain drugs at specific times relative to your Mounjaro injection.
What should I tell my prescriber about my ulcerative colitis?
Provide complete information about your diagnosis date, current disease activity, medications (including biologics), recent colonoscopy results, frequency of flares, and any complications. Comprehensive information allows prescribers to make the safest treatment recommendations for your circumstances.
Can Mounjaro help with weight gain caused by steroid treatment for ulcerative colitis?
Mounjaro may help address weight gain from corticosteroid treatment, but prescribers must ensure your ulcerative colitis is stable before starting weight loss medication. Patients currently taking high-dose steroids for active disease may need to achieve remission first.
Where can I buy Mounjaro with ulcerative colitis in the UK?
Mounjaro is available through Cured Pharmacy from £124.99 after completing a clinical assessment. Our UK-registered prescribers will review your ulcerative colitis history and current status to determine whether tirzepatide is appropriate for your individual circumstances.
Can I use Mounjaro if I have ulcerative colitis in the UK?
Mounjaro is not contraindicated for ulcerative colitis, but gastrointestinal conditions require careful assessment. Cured Pharmacy's UK-registered prescribers will review your full medical history, including your UC diagnosis and current medications, during your online consultation to ensure Mounjaro is safe and appropriate for you.
Does Mounjaro worsen symptoms of ulcerative colitis?
Mounjaro's common side effects include nausea, diarrhoea, and abdominal discomfort, which may overlap with ulcerative colitis symptoms. If you have active UC or inflammatory bowel disease, your prescriber at Cured Pharmacy will consider whether these potential side effects could complicate your condition before approval.
Is Mounjaro the cheapest weight loss option for UK patients with ulcerative colitis?
Mounjaro starts from £124.99 at Cured Pharmacy, making it one of the most affordable GLP-1 options in the UK. For patients managing ulcerative colitis alongside weight concerns, our prescribers can discuss whether Mounjaro or alternative treatments are most suitable based on your individual health profile.
Will my ulcerative colitis medication interact with Mounjaro?
Mounjaro can slow gastric emptying, potentially affecting absorption of oral medications including some UC treatments. Cured Pharmacy's prescribers will review all your current medications during consultation to identify any interactions and advise on timing or adjustments if Mounjaro is prescribed.
How do I get Mounjaro assessed safely with ulcerative colitis in the UK?
Complete Cured Pharmacy's online consultation form, clearly detailing your ulcerative colitis diagnosis, severity, current treatments, and any recent flares. Our UK-registered prescribers will conduct a thorough assessment to determine if Mounjaro is clinically appropriate, ensuring your inflammatory bowel condition is managed safely.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 13 August 2026

Last updated on 13 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 13 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (13 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.